YE WEIGUO (Chief Operating Officer) sold 1.5% of their position (11K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $68.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3K
Price / share
$0.75
Trade value
$2.25K
% of position
Common Stock
Shares
−3K
Price / share
$6.15
Trade value
$18.45K
% of position
Common Stock
Shares
+5K
Price / share
$0.75
Trade value
$3.75K
% of position
Common Stock
Shares
−5K
Price / share
$6.24
Trade value
$31.20K
% of position
Common Stock
Shares
+3K
Price / share
$0.75
Trade value
$2.25K
% of position
Common Stock
Shares
−3K
Price / share
$6.35
Trade value
$19.05K
% of position
Net shares
+0.00
Net value
-$60.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2026 | M · Option Exercise | +3K | $0.75 | $2.25K | 0.4% | 700K | 703K |
| Common Stock Direct | 6/9/2026 | S · Sale | −3K | $6.15 | $18.45K | 0.4% | 703K | 700K |
| Common Stock Direct | 6/10/2026 | M · Option Exercise | +5K | $0.75 | $3.75K | 0.7% | 700K | 705K |
| Common Stock Direct | 6/10/2026 | S · Sale | −5K | $6.24 | $31.20K | 0.7% | 705K | 700K |
| Common Stock Direct | 6/18/2026 | M · Option Exercise | +3K | $0.75 | $2.25K | 0.4% | 700K | 703K |
| Common Stock Direct | 6/18/2026 | S · Sale | −3K | $6.35 | $19.05K | 0.4% | 703K | 700K |
| Total | +0.00 | -$60.45K | ||||||
Stock Option (Right to Buy)
Common Stock
3K shares
Shares
−3K
Strike price
0.75
Held after
835.70K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
5K shares
Shares
−5K
Strike price
0.75
Held after
830.70K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
3K shares
Shares
−3K
Strike price
0.75
Held after
827.70K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3K shares | 6/9/2026 | M · Option Exercise | −3K | 0.75 | — | 835.70K |
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 6/10/2026 | M · Option Exercise | −5K | 0.75 | — | 830.70K |
| Stock Option (Right to Buy) Direct | Common Stock3K shares | 6/18/2026 | M · Option Exercise | −3K | 0.75 | — | 827.70K |